Hikma Pharmaceuticals (HIK) Ordinary GBP 0.10
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
London close: Stocks rise as BoE keeps rates on hold
21 March 2024 16:33
(Sharecast News) - London markets closed higher on Thursday, sustaining gains after the Bank of England adhered to expectations by maintaining interest rates at a 16-year high.
-
Berenberg slightly raises target price on Hikma Pharmaceuticals
27 February 2024 09:40
(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,960.0p to 2,000.0p on Tuesday, citing more stability in its generics unit.
-
London close: Stocks rise amid raft of solid earnings
22 February 2024 16:26
(Sharecast News) - London's stock markets finished in positive territory on Thursday, bolstered by upbeat performances from US AI chipmaker Nvidia and engine manufacturer Rolls-Royce.
-
Hikma lifts dividend after double-digit growth in 2023
22 February 2024 07:51
(Sharecast News) - Hikma Pharmaceuticals impressed the market with its annual results on Thursday as it bumped up its dividend by almost a third following double-digit growth in core revenues and profits in...
-
Hikma agrees to settle US opioid claims
2 February 2024 07:23
(Sharecast News) - Hikma Pharmaceuticals announced an agreement in principle to address the majority of opioid-related claims filed against it by various US states, local communities and tribal nations on...
-
Jefferies downgrades Hikma to 'hold'
7 November 2023 13:08
(Sharecast News) - Jefferies downgraded Hikma Pharmaceuticals on Tuesday to 'hold' from 'buy' and cut the price target to 1,940p from 2,125p.
-
Berenberg stays at 'hold' on Hikma Pharmaceuticals
6 November 2023 12:01
(Sharecast News) - Analysts at Berenberg reiterated their 'hold' rating and 2,100.0p target price on Hikma Pharmaceuticals on Monday, saying a "lighter" second half was playing out in its...
-
London close: Stocks rise as BoE keeps rates steady
2 November 2023 15:12
(Sharecast News) - London's stock markets ended the day on a positive note on Thursday, following the Bank of England's decision to maintain interest rates as markets widely expected.
-
Hikma adjusts expectations amid injectables challenges
2 November 2023 08:03
(Sharecast News) - Hikma Pharmaceuticals reported solid global growth in its injectables business on Thursday, with strong customer demand for its product portfolio in North America, although some challenges...
-
Hikma announces new president of injectables business
9 August 2023 08:25
(Sharecast News) - Hikma Pharmaceuticals announced the appointment of Dr Bill Larkins as the new president of its injectables business on Wednesday.
-
Hikma lifts guidance for generics business
3 August 2023 07:51
(Sharecast News) - Hikma Pharmaceuticals lifted annual revenue and margin guidance for its generics business as first-half core operating profit rose 35%.
-
Hikma surges after tornado damages Pfizer injectables plant
20 July 2023 08:53
(Sharecast News) - Hikma Pharmaceuticals surged on Thursday, with traders pointing to news that a major Pfizer injectables plant in North Carolina was hit by a tornado and heavily damaged on Wednesday.
Company announcements Announcements
-
Director/PDMR Shareholding
17 April 2024 10:42
Hikma Pharmaceuticals
-
Hikma appoints new President of Generics business
15 April 2024 16:43
Hikma Pharmaceuticals
-
Block listing Interim Review
2 April 2024 09:50
Hikma Pharmaceuticals
-
Annual Financial Report and Notice of AGM
22 March 2024 09:21
Hikma Pharmaceuticals
-
Director/PDMR Shareholding
13 March 2024 09:42
Hikma Pharmaceuticals
-
Director/PDMR Shareholding
7 March 2024 13:52
Hikma Pharmaceuticals
-
Total Voting Rights
1 March 2024 10:17
Hikma Pharmaceuticals
-
Final Results
22 February 2024 07:00
Hikma Pharmaceuticals
-
Notice of Results
5 February 2024 08:46
Hikma Pharmaceuticals
-
Agreement in Principle for US Opioid Settlement
1 February 2024 18:22
Hikma Pharmaceuticals
-
Total Voting Rights
1 February 2024 12:08
Hikma Pharmaceuticals
-
Total Voting Rights
2 January 2024 15:24
Hikma Pharmaceuticals
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.